Home > Boards > US Listed > Medical - Drugs > Antares Pharma, Inc. (ATRS)

From MS World about Copaxone TTW timeline

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Rymankoly Member Profile
Member Level 
Followed By 41
Posts 2,424
Boards Moderated 0
Alias Born 12/17/01
160x600 placeholder
Antares Pharma's ATRS-1902 gets US FDA fast track status for adrenal crisis rescue Seeking Alpha - 1/18/2022 12:20:51 PM
Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue GlobeNewswire Inc. - 1/18/2022 7:30:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 1/12/2022 9:06:25 AM
Antares Pharma Appoints Claude E. Richardson as Senior Vice President of Human Resources GlobeNewswire Inc. - 1/12/2022 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2022 9:04:27 AM
Antares Pharma reports positive results from Phase I ATRS-1902 study for adrenal crisis Seeking Alpha - 1/11/2022 9:04:03 AM
Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue GlobeNewswire Inc. - 1/11/2022 7:30:00 AM
MedMira strengthen its Board with New Appointment GlobeNewswire Inc. - 12/17/2021 7:53:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/16/2021 4:08:49 PM
Antares Pharma Announces Divestiture of Otrexup® GlobeNewswire Inc. - 12/15/2021 5:58:23 PM
Antares Pharma to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference GlobeNewswire Inc. - 11/22/2021 8:00:00 AM
Antares Pharma to Present at the Jefferies London Healthcare Conference GlobeNewswire Inc. - 11/10/2021 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2021 4:42:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2021 7:09:53 AM
Antares Pharma EPS in-line, beats on revenue Seeking Alpha - 11/4/2021 7:03:20 AM
Antares Pharma Reports Third Quarter 2021 Financial and Operating Results GlobeNewswire Inc. - 11/4/2021 7:00:00 AM
Antares Pharma Q3 2021 Earnings Preview Seeking Alpha - 11/3/2021 11:20:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2021 4:54:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/29/2021 6:15:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/28/2021 8:14:20 AM
Antares Pharma Announces Appointment of Carmen Volkart to its Board of Directors GlobeNewswire Inc. - 10/28/2021 8:00:00 AM
Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA GlobeNewswire Inc. - 10/25/2021 8:30:00 AM
Antares Pharma to Report Third Quarter 2021 Financial and Operating Results GlobeNewswire Inc. - 10/21/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2021 7:56:58 AM
Antares Pharma Enters into Exclusive License Agreement With Lipocine for TLANDO® in U.S. GlobeNewswire Inc. - 10/18/2021 7:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences